COVID-19: Warp Speed vaccines

被引:5
|
作者
Feraoun, Yanis [1 ]
Maisonnasse, Pauline [1 ]
Le Grand, Roger [1 ]
Beignon, Anne-Sophie [1 ]
机构
[1] Univ Paris Saclay, Dept IDMIT Infect Dis Models & Innovat Therapies, CEA,UMR 1184,Unite Inserm 1184, Immunol Malad Virales Autoimmunes Hematol & Bacte, 18 Route Panorama, F-92265 Fontenay Aux Roses, France
来源
M S-MEDECINE SCIENCES | 2021年 / 37卷 / 8-9期
关键词
NCOV-19; AZD1222; VACCINE; SARS-COV-2; INFECTION; EFFICACY; MEMORY; IMMUNOGENICITY; BNT162B2; HEALTH; PHASE-1; WORKERS; SAFETY;
D O I
10.1051/medsci/2021094
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A vaccine is required to effectively control the COVID-19 pandemic in the mid and long term. The development of vaccines against SARS-CoV-2 was initiated as soon as the genetic sequence of the virus was published, and has evolved at an unprecedented speed, with a first clinical trial launched in March 2020. One year later, more than a dozen of vaccines based on different concepts, with some having been evaluated only in clinical trials so far, are authorized under emergency procedures. Here, we review these vaccines, compare their properties and discuss the challenges they face, including the emergence of viral variants of concern.
引用
收藏
页码:759 / 772
页数:14
相关论文
共 50 条
  • [1] COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds
    Moore, John P.
    Klasse, P. J.
    JOURNAL OF VIROLOGY, 2020, 94 (17)
  • [2] Criteria for judging the immune markers of COVID-19 disease vaccines
    Lin, Nan
    Fu, Haoxuan
    Pu, Dan
    Quan, Yuxin
    Li, Yueyi
    Yin, Xiaomeng
    Wei, Yuhao
    Wang, Hang
    Ma, Xuelei
    Wei, Xiawei
    MEDCOMM, 2022, 3 (01):
  • [3] COVID-19 Vaccines and the Efficacy of Currently Available Vaccines Against COVID-19 Variants
    Selvam, Suganya Panneer
    Ramani, Pratibha
    Ramya, R.
    Sundar, Sandhya
    Lakshmi, T. A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [4] Considerations for the Feasibility of Neutralizing Antibodies as a Surrogate Endpoint for COVID-19 Vaccines
    Liu, Jianyang
    Mao, Qunying
    Wu, Xing
    He, Qian
    Bian, Lianlian
    Bai, Yu
    Wang, Zhongfang
    Wang, Qian
    Zhang, Jialu
    Liang, Zhenglun
    Xu, Miao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [5] Efficacy and Safety of COVID-19 Vaccines-An Update
    Sharma, Eshani
    Revinipati, Sraddha
    Bhandari, Saisha
    Thakur, Sejal
    Goyal, Shubham
    Ghose, Aruni
    Bajpai, Sukrit
    Muhammad, Waleed
    Boussios, Stergios
    DISEASES, 2022, 10 (04)
  • [6] Delivery Routes for COVID-19 Vaccines
    Park, Jang Hyun
    Lee, Heung Kyu
    VACCINES, 2021, 9 (05)
  • [7] COVID-19 Vaccines: Current Status and Implication for Use in Indonesia
    Ophinni, Youdiil
    Hasibuan, Anshari S.
    Widhani, Alvina
    Maria, Suzy
    Koesnoe, Sukamto
    Yunihastuti, Evy
    Karjadi, Teguh H.
    Rengganis, Iris
    Djauzi, Samsuridjal
    ACTA MEDICA INDONESIANA, 2020, 52 (04) : 388 - 412
  • [8] COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
    Zasada, Aleksandra Anna
    Darlinska, Aniela
    Wiatrzyk, Aldona
    Woznica, Katarzyna
    Forminska, Kamila
    Czajka, Urszula
    Glowka, Malgorzata
    Lis, Klaudia
    Gorska, Paulina
    VIRUSES-BASEL, 2023, 15 (09):
  • [9] The Interplay of Lung Cancer, COVID-19, and Vaccines
    Trivanovic, Dragan
    Persuric, Zeljka
    Agaj, Andrea
    Jakopovic, Marko
    Samarzija, Miroslav
    Bitar, Lela
    Pavelic, Kresimir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [10] Safety & effectiveness of COVID-19 vaccines: A narrative review
    Chirico, Francesco
    Teixeira da Silva, Jaime A.
    Tsigaris, Panagiotis
    Sharun, Khan
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2022, 155 (01) : 91 - 104